Top of this page
Skip navigation, go straight to the content

Our Science Our clinical studies Alprostadil (Prostavasin®)

Clinical Study Information - Prostavasin® (alprostadil)

Disease area
studied
Abbreviated title Phase Study ID Registry database Study results Study summary Publication (if available)
Intermittent Claudication Prostaglandin E1 in Outpatients With Intermittent Claudication Phase 3 SP0580
Completed
NCT01263925

LINK 
Schellong SM, et al. Vasa; 2017,46(5):403-405
Peripheral Arterial Occlusive Disease Alprostadil in Peripheral Arterial Occlusive Disease (PAOD) Stage IV (ESPECIAL) Phase 4 SP0777
Completed
NCT00596752 LINK
Lawall, H. et al. Eur J Vasc Endovasc Surg; 2017, 53(4):559-566
Macular Degeneration Alprostadil in Maculopathy Study (AIMS) Phase 3 SP0878
Terminated
NCT00619229 LINK
LINK

Augustin et al. Expert Opin Investig Drugs; 2013;22;7; 803-812.